Search

everythinglearnresearchcommunity

for

Search:↓

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Recent advances in hair loss treatments show significant progress.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Long-term use of dutasteride can cause permanent erectile dysfunction in rats.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

A woman with severe angioedema improved significantly after treatment with rituximab.

A cholesterol-free liposomal platform using protopanaxadiol effectively promotes hair growth and treats alopecia.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

The equine epididymis mainly uses type 1 5α-reductase, and both finasteride and dutasteride can inhibit its activity.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Hair restoration techniques like follicular unit transplant surgery and follicular unit extraction are effective, with ideal graft placement density between 20-30 units per cm². Medications like Minoxidil and Finasteride can help maintain and regrow hair.

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

Certain drugs change freshwater snail shells to a "banana" shape.

Nonsurgical treatments like minoxidil and laser therapy offer various options to manage hair loss effectively.

There is no strong evidence that chemopreventive agents effectively prevent prostate cancer.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.